Most studies that focus on immune diseases, such as rheumatoid arthritis, psoriasis or multiple sclerosis, and the key factors related to pathogenic differentiation of Th17 and Th22 cells and the production of IL-17 and IL-22 in their course, emphasize the pro-inflammatory importance of IL-6. Here, IL22 is linked to psoriasis.